Biomarker & Intervention Discovery

Other Musculoskeletal Disorders

This page lists 5 druggable gene targets for Other Musculoskeletal Disorders, with each agent ranked by the strength of its evidence (clinical, mechanistic or correlative). Sources are linked so you can check every claim.

Disease Overview

Spontaneous remission
Not established
Best-intervention remission
—
Gap size
—
Primary barrier
—

Biomarker Targets & Therapeutic Agents

Gene targets queried against DGIdb, Open Targets, ChEMBL, PubMed, and Europe PMC. Agents ranked: Clinical > Mechanistic > Correlative.

IL6 173PTGS2 299SCN9A 271TNF 277TRPV1 160
Therapeutic Agent Effect Direction Evidence Tier Potency Source
CISPLATIN ? unclear Mechanistic
ZILTIVEKIMAB ~ modulates Mechanistic
CHINESE HERBS ? unclear Mechanistic
PF-04236921 ↓ inhibits Mechanistic
MRA 003 US ↓ inhibits Mechanistic
SIGNAL TRANSDUCTION INHIBITOR ? unclear Mechanistic
BINETRAKIN ? unclear Mechanistic
IBUDILAST ? unclear Mechanistic
INSULIN, REGULAR, HUMAN ? unclear Mechanistic
SILTUXIMAB ↓ inhibits Mechanistic
METRONIDAZOLE ? unclear Mechanistic
CLAZAKIZUMAB ↓ inhibits Mechanistic
GALLIUM NITRATE ? unclear Mechanistic
INTERFERON ALFA-2B ? unclear Mechanistic
DULOXETINE HYDROCHLORIDE ? unclear Mechanistic
MEDI-5117 ↓ inhibits Mechanistic
GEMFIBROZIL ? unclear Mechanistic
BIAFINE CREAM ? unclear Mechanistic
ETANERCEPT ? unclear Mechanistic
ELSILIMOMAB ↓ inhibits Mechanistic
SAQUINAVIR ? unclear Mechanistic
INFLIXIMAB ? unclear Mechanistic
LINEZOLID ? unclear Mechanistic
IFOSFAMIDE ? unclear Mechanistic
OLOKIZUMAB ↓ inhibits Mechanistic
HMG-COA REDUCTASE INHIBITOR ? unclear Mechanistic
MIDOSTAURIN ? unclear Mechanistic
SELENIUM ? unclear Mechanistic
SIRUKUMAB ↓ inhibits Mechanistic
PEGINTERFERON ALFA-2B ? unclear Mechanistic
ECHINACEA PREPARATION ? unclear Mechanistic
ENZYME INHIBITOR ? unclear Mechanistic
FENOFIBRATE MICRONIZED ? unclear Mechanistic
VITAMIN K ? unclear Mechanistic
PEGINTERFERON ALFA-2A ? unclear Mechanistic
RIBAVIRIN ? unclear Mechanistic
VITAMIN A PALMITATE ? unclear Mechanistic
ARSENIC TRIOXIDE ? unclear Mechanistic
DIHYDROSPHINGOSINE ? unclear Mechanistic
LEVOFLOXACIN ANHYDROUS ? unclear Mechanistic

Showing top 40 of 173 agents ranked by evidence tier.

Therapeutic Agent Effect Direction Evidence Tier Potency Source
CARPROFEN ↓ inhibits Mechanistic 102.0 nM (IC50)
INDOMETHACIN SODIUM ↓ inhibits Mechanistic
DARBUFELONE ? unclear Mechanistic
MEFENAMIC ACID ↓ inhibits Mechanistic
MECLOFENAMATE SODIUM ↓ inhibits Mechanistic
DICLOFENAC SODIUM ↓ inhibits Mechanistic
CAPECITABINE ? unclear Mechanistic
PIRPROFEN ↓ inhibits Mechanistic
ESFLURBIPROFEN ↓ inhibits Mechanistic
SULFASALAZINE ↓ inhibits Mechanistic
BROMFENAC ? unclear Mechanistic
IBUPROFEN, SODIUM SALT ↓ inhibits Mechanistic
ALOXIPRIN ↓ inhibits Mechanistic
TENOXICAM ? unclear Mechanistic
FLURBIPROFEN ↓ inhibits Mechanistic
SALICYLIC ACID ? unclear Mechanistic
ATENOLOL ? unclear Mechanistic
DEXKETOPROFEN ↓ inhibits Mechanistic
ETORICOXIB ↓ inhibits Mechanistic
LUMIRACOXIB ↓ inhibits Mechanistic
SUPROFEN ↓ inhibits Mechanistic
NS-398 ? unclear Mechanistic
NABUMETONE ↓ inhibits Mechanistic
URSOLIC ACID ? unclear Mechanistic
IBUPROFEN LYSINE ↓ inhibits Mechanistic
ACECLOFENAC ↓ inhibits Mechanistic
IBUFENAC ↓ inhibits Mechanistic
BALSALAZIDE ? unclear Mechanistic
DIFLUNISAL ↓ inhibits Mechanistic
BALSALAZIDE DISODIUM ↓ inhibits Mechanistic
VACCINE ? unclear Mechanistic
KETOROLAC TROMETHAMINE ↓ inhibits Mechanistic
BENZYDAMINE HYDROCHLORIDE ↓ inhibits Mechanistic
TIAPROFENIC ACID ? unclear Mechanistic
RALOXIFENE HYDROCHLORIDE ? unclear Mechanistic
NAPROXCINOD ↓ inhibits Mechanistic
IGURATIMOD ↓ inhibits Mechanistic
ETODOLAC ↓ inhibits Mechanistic
DICLOFENAC ETALHYALURONATE SODIUM ↓ inhibits Mechanistic
ROFECOXIB ↓ inhibits Mechanistic 530.0 nM (IC50)

Showing top 40 of 299 agents ranked by evidence tier.

Therapeutic Agent Effect Direction Evidence Tier Potency Source
MERETHOXYLLINE PROCAINE ↓ inhibits Mechanistic
ETIDOCAINE HYDROCHLORIDE ↓ inhibits Mechanistic
FOSPHENYTOIN ↓ inhibits Mechanistic
VERATRIDINE ↑ activates Mechanistic
ORPHENADRINE CITRATE ↓ inhibits Mechanistic
PHENACEMIDE ↓ inhibits Mechanistic
LACOSAMIDE ↓ inhibits Mechanistic
VIXOTRIGINE ↓ inhibits Mechanistic
DSP-2230 ↓ inhibits Mechanistic
SAXITOXIN ↓ inhibits Mechanistic
ESLICARBAZEPINE ACETATE ↓ inhibits Mechanistic
SAFINAMIDE ? unclear Mechanistic
LIDOCAINE ↓ inhibits Mechanistic
RILUZOLE ↓ inhibits Mechanistic
ROPIVACAINE HYDROCHLORIDE ↓ inhibits Mechanistic
FUNAPIDE ↓ inhibits Mechanistic
DYCLONINE HYDROCHLORIDE ↓ inhibits Mechanistic
EVENAMIDE ↓ inhibits Mechanistic
PROPOFOL ? unclear Mechanistic
AM-6120 ↓ inhibits Mechanistic
RG7893 ↓ inhibits Mechanistic
RG6029 ↓ inhibits Mechanistic
QUINIDINE SULFATE ↓ inhibits Mechanistic
ZONISAMIDE ↓ inhibits Mechanistic
NERISPIRDINE ↓ inhibits Mechanistic
RALFINAMIDE ↓ inhibits Mechanistic
DS-1971A ↓ inhibits Mechanistic
HEXYLCAINE HYDROCHLORIDE ↓ inhibits Mechanistic
MEPIVACAINE HYDROCHLORIDE ↓ inhibits Mechanistic
PROCAINAMIDE HYDROCHLORIDE ↓ inhibits Mechanistic
PROPAFENONE HYDROCHLORIDE ↓ inhibits Mechanistic
LIDOCAINE HYDROCHLORIDE ↓ inhibits Mechanistic
QUINIDINE GLUCONATE ↓ inhibits Mechanistic
PRILOCAINE ↓ inhibits Mechanistic
ETHOTOIN ↓ inhibits Mechanistic
PF-05089771 ↓ inhibits Mechanistic
DICHLOROBENZYL ALCOHOL ↓ inhibits Mechanistic
RANOLAZINE ? unclear Mechanistic
PRILOCAINE HYDROCHLORIDE ↓ inhibits Mechanistic
ORPHENADRINE HYDROCHLORIDE ↓ inhibits Mechanistic

Showing top 40 of 271 agents ranked by evidence tier.

Therapeutic Agent Effect Direction Evidence Tier Potency Source
NERELIMOMAB ↓ inhibits Mechanistic
CROMOLYN SODIUM ? unclear Mechanistic
PLACULUMAB ↓ inhibits Mechanistic
METHYLENE BLUE ? unclear Mechanistic
ALTEPLASE ? unclear Mechanistic
CARBOPLATIN ? unclear Mechanistic
GENTAMICIN ? unclear Mechanistic
GOLIMUMAB ↓ inhibits Mechanistic
BUPIVACAINE ? unclear Mechanistic
PENTOXIFYLLINE ? unclear Mechanistic 85000.0 nM (IC50)
BENZO[E]PYRENE ? unclear Mechanistic
THALIDOMIDE ? unclear Mechanistic
PYRAZINAMIDE ? unclear Mechanistic
GLIMEPIRIDE ? unclear Mechanistic
OMEPRAZOLE ? unclear Mechanistic
LENERCEPT ↓ inhibits Mechanistic
ADALIMUMAB ↓ inhibits Mechanistic
PRAZOSIN HYDROCHLORIDE ? unclear Mechanistic
REMTOLUMAB ? unclear Mechanistic
MIDOSTAURIN ? unclear Mechanistic
LENABASUM ? unclear Mechanistic
MAGNESIUM SULFATE ANHYDROUS ? unclear Mechanistic
PICIBANIL ? unclear Mechanistic
FLUOCINOLONE ACETONIDE ? unclear Mechanistic
MILTEFOSINE ? unclear Mechanistic
HOMIDIUM BROMIDE ? unclear Mechanistic
OZORALIZUMAB ↓ inhibits Mechanistic
PEGSUNERCEPT ↓ inhibits Mechanistic
CERTOLIZUMAB PEGOL ↓ inhibits Mechanistic
THERAPEUTIC HORMONE ? unclear Mechanistic
NAFAMOSTAT ? unclear Mechanistic
FOLIC ACID ? unclear Mechanistic
ABBV-257 ? unclear Mechanistic
RISPERIDONE ? unclear Mechanistic
COVA322 ? unclear Mechanistic
HYDROXYCHLOROQUINE ? unclear Mechanistic
CERTOLIZUMAB ? unclear Mechanistic
AN0128 ? unclear Mechanistic
5,7-DIHYDROXY-4-METHYLCOUMARIN ? unclear Mechanistic
SORAFENIB ? unclear Mechanistic

Showing top 40 of 277 agents ranked by evidence tier.

Therapeutic Agent Effect Direction Evidence Tier Potency Source
STREPTOZOCIN ? unclear Mechanistic
BENZYL ISOTHIOCYANATE ? unclear Mechanistic
ACETAMINOPHEN ↑ activates Mechanistic
POLYGODIAL ? unclear Mechanistic
PROPOFOL ? unclear Mechanistic
SAF312 ↓ inhibits Mechanistic
GRC-15300 ? unclear Mechanistic
AZD1386 ↓ inhibits Mechanistic
TIVANISIRAN ↓ inhibits Mechanistic
MAVATREP ↓ inhibits Mechanistic
MR-1817 ↓ inhibits Mechanistic
FERRUGINENE B ? unclear Mechanistic
CAPSAICIN ↑ activates Mechanistic 19.95 nM (EC50)
RECOMBINANT TUMOR NECROSIS FACTOR FAMILY PROTEIN ? unclear Mechanistic
PHENETHYLISOTHIOCYANATE ? unclear Mechanistic
VOACANGINE ? unclear Mechanistic
RESINIFERATOXIN ↑ activates Mechanistic 23.1 nM (Ki)
DWP05195 ↓ inhibits Mechanistic
XEN-D0501 ↓ inhibits Mechanistic
PAC-14028 ↓ inhibits Mechanistic
SB-705498 ↓ inhibits Mechanistic
MASOPROCOL ? unclear Mechanistic
ALLYL ISOTHIOCYANATE ? unclear Mechanistic
NGD-8243 ↓ inhibits Mechanistic
GRC-6211 ↓ inhibits Mechanistic
RESERPINE ? unclear Mechanistic
NABIXIMOLS ? unclear Mechanistic
A425619 ? unclear Mechanistic
PHE377 ↓ inhibits Mechanistic
ANTISENSE OLIGONUCLEOTIDES ? unclear Mechanistic
WORTMANNIN ? unclear Mechanistic
JTS-653 ↓ inhibits Mechanistic
LEVODOPA ? unclear Mechanistic
AMG517 ↓ inhibits Mechanistic
CAPSAZEPINE ? unclear Mechanistic 120.0 nM (Ki)
ZUCAPSAICIN ↑ activates Mechanistic
INDOMETHACIN ? unclear Mechanistic
CHEMBL:CHEMBL191534 ? unclear Mechanistic
ABT-102 ↓ inhibits Mechanistic
ISOPROPYL ISOTHIOCYANATE ? unclear Mechanistic

Showing top 40 of 160 agents ranked by evidence tier.


Clinical Trials

Drug, biologic and supplement trials (treatment or prevention) from ClinicalTrials.gov whose main condition is Other Musculoskeletal Disorders: recruiting, active or completed, most recently updated first. Data retrieved 2026-10-28.

No recruiting, active or completed drug trials with this main condition were found on ClinicalTrials.gov.


Agents Found By Disease-Level Search

Searched directly from “Other Musculoskeletal Disorders” via ClinicalTrials.gov interventions and Open Targets' disease→drug data — independent of the 5-gene target panel above. This surfaces agents whose mechanism doesn't route through a curated gene (combination therapies, standard-of-care drugs, targets outside the panel).

Not yet run. python -m biomarker_pipeline.run_disease_agent_discovery --disease "..."